Ponce, Kiarrah Jewelrich S.
HRN: 22-64-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2023
CEFUROXIME 750MG (VIAL)
02/24/2023
03/02/2023
IV
650mg
Q8Hrs
Intestinal Amoebiasis; UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractBloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes